Canada Research Roundup: Converge Technology Solutions, Dialogue Health Technologies, Softchoice

Docebo

14/06/2022 08:40

June 14 (Reuters) - Securities analysts revised their ratings and price targets on several
Canadian companies, including Converge Technology Solutions, Dialogue Health Technologies and
Softchoice, on Tuesday. 
    
    
  HIGHLIGHTS
     * Converge Technology Solutions Corp  CTS.TO : CIBC cuts target price to C$7 from C$11
     * Dialogue Health Technologies  CARE.TO : CIBC cuts to neutral from outperformer
     * Q4 Inc  QFOR.TO : CIBC cuts to neutral from outperformer
     * Softchoice Corp (Ca)  SFTC.TO : CIBC cuts to neutral from outperformer
    
Following is a summary of research actions on Canadian companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order. 
     
     * Converge Technology Solutions Corp  CTS.TO : CIBC cuts target price to C$7 from C$11
     * Dialogue Health Technologies  CARE.TO : CIBC cuts to neutral from outperformer
     * Dialogue Health Technologies  CARE.TO : CIBC cuts target price to C$4 from C$7
     * Docebo Inc  DCBO.TO : CIBC cuts target price to C$54 from C$63.50
     * Magnet Forensics Inc  MAGT.TO : CIBC cuts target price to C$25 from C$34
     * Q4 Inc  QFOR.TO : CIBC cuts target price to C$5 from C$8
     * Q4 Inc  QFOR.TO : CIBC cuts to neutral from outperformer
     * Softchoice Corp (Ca)  SFTC.TO : CIBC cuts target price to C$21 from C$26
     * Softchoice Corp (Ca)  SFTC.TO : CIBC cuts to neutral from outperformer
    

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))